LAG3 and central nervous system cancer: Although the expression of LAG3 is controversial in gliomas, it is possible that the expression of this immunological checkpoint could raise in response to the inflammatory infiltration induced by immunotherapeutic strategies, such as anti-mIDH vaccines.